Skip to main content
Erschienen in: World Journal of Surgical Oncology 1/2007

Open Access 01.12.2007 | Case report

Local recurrence and distant metastases 18 years after resection of the greater omentum hemangiopericytoma

verfasst von: Maciej Slupski, Ilona Piotrowiak, Zbigniew Wlodarczyk

Erschienen in: World Journal of Surgical Oncology | Ausgabe 1/2007

download
DOWNLOAD
print
DRUCKEN
insite
SUCHEN

Abstract

Background

Hemangiopericytoma occurs with increasing frequency in 5th decade of life and has prediction for retroperitoneum and extremities. A case of a local recurrence and metastases of hemangiopericytoma is described.

Case presentation

Recurrence of hemangiopericytoma in the greater omentum and the jejunal mesentery as well as metastases in the retroperitoneal space were diagnosed in a 61-year-old patient who had a hemangiopericytoma of the greater omentum excised 18 years before.

Conclusion

Because of the rarity of this disease and its typical clinical course associated with late recurrence and metastases, the authors decided to present this case emphasizing the necessity of systematic oncological follow-up after the end of treatment.
Hinweise

Electronic supplementary material

The online version of this article (doi:10.​1186/​1477-7819-5-63) contains supplementary material, which is available to authorized users.

Competing interests

The authors declare that they have no competing interests.

Authors' contributions

MS conceived the idea for the study, participated in its design and coordination, analyzed the data, wrote the first draft of the manuscript.
IP conducted the literature review, was involved in data collection, analyzed the data, helped to draft the manuscript.
ZW participated in the study design and coordination, helped to draft the manuscript.
All authors read and approved the final version of the manuscript.

Background

Hemangiopericytoma is a tumor originating from the vascular pericytes of Zimmermann. Most frequently it occurs in patients aged 40 and above with its main localization in the retroperitoneum, pelvis and lower extremities [13], however, it may occur at any age in almost any part of body [4]. One of the typical features of this tumor is that both metastasis and recurrence could become apparent even after several years in remission [57].
We report the case of a local recurrence and metastases in the retroperitoneum infiltrating the liver and diaphragm in a 61-year-old patient operated on due to a hemangiopericytoma of the greater omentum 18 years before.

Case presentation

A 61-year-old patient was admitted to the Department of Transplantation and General Surgery with a tumor diagnosed in the left lumbar and retroperitoneal space. Eighteen years before he had been operated for a tumor of the greater omentum with histopathological diagnosis haemangiopericytoma omenti maioris, until now with no recurrence nor distant metastases were found.
On admission the patient was in good general condition with left lumbar pain and a mobile tumor in this area. Abdominal ultrasonography (US) and computed tomography (CT) revealed a retroperitoneum space tumor with suspected infiltration of the segment VII of the liver and diaphragm.
Laboratory investigation showed no abnormalities. The patient was qualified for surgical treatment. A tumor of 5 cm in diameter in the greater omentum tightly adjacent to a transverse colon (figure 1), a tumor of 1 cm in diameter in the jejunum mesentery (figure 2, arrow) and a tumor of 12 cm in diameter located in the retroperitoneal space and infiltrating the diaphragm and the segment VII of the liver were found. No other lesions were found in intraoperative US. The tumors of the greater omentum and of the jejunum mesentery were excised whereas the retroperitoneal space tumor was removed en bloc with the infiltrated part of the diaphragm and the segment VII of the liver (figure 3, and 4). The postoperative course proved uneventful. The patient was discharged from the hospital 7 days after the procedure in good general condition with a subsequent surgical follow-up recommended.
Histopathological examination of all the lesions showed haemangiopericytoma malignum. The patient remains under the Oncology Centre and our clinical follow-up and at present, 3 months after the procedure, is in good condition.

Discussion

Hemangiopericytomas represent less than 1% of all vascular neoplasms [8]. They are highly vascular, therefore could be revealed by angio-CT and angiography (for diagnosis, tumor size, relationship to other viscera, source of blood supply) as well as undergo preoperative transarterial embolization if necessary [3, 5]. The tumors' medium size is 6.5 cm and they are encapsulated by a pseudocapsule [1, 3]. There is no grading scale for hemangiopericytoma; its malignant potential is implied by histology and clinical behavior [5]. Hypervascularity is a contraindication to a biopsy, therefore a histopathological diagnosis is established after an excision of the lesion. Potentially malignant tumors are characterized by 1 mitotic figure per 10 high-power field and moderate anaplasia. According to McMaster et al., 25 of 32 (78%) malignant tumors, 6 of 16 (37.5%) borderline lesions and no benign tumors metastasised [6].
Metastases occur by hematogenous and lymphogenous routes affecting mainly the lung, liver, bones and regional lymph nodes [1, 3, 9, 10]. Metastasis to pleura have also been reported [11]. Metastases occurring many years after excision of a primary lesion is typical of hemangiopericytoma: In our case it was 18 years. Multiple hepatic and bone metastases 12 years after an excision of a nose tumor have been reported [12]. McMaster et al., reveal that metastases became apparent in 11% of patients with malignant tumors and 7% with borderline tumors after 5 years' remission [6]. Local recurrence is also common and precedes metastases in more than 2/3 of cases [1, 13]. In two cases presented by Panda et al., it occurred after 4 months in one patient and 22 years in another [7]. Therefore long-term follow-up is essential [6]. Hypercellularity, mitotic activity, anaplasia, necrosis and hemorrhage are reported to be associated with higher malignant potential [13].
Surgical resection with subsequent radiotherapy remains the treatment of choice for hemangiopericytoma. The role of preoperative angiography and tumor embolization is also emphasized in literature [3, 5, 6]. Survival rates vary: In a review of 106 cases of hemangiopericytoma, Enzinger et al., reported 70% 10-year survival, whereas it was 50% 5-year survival according to other authors [1, 10].
Late recurrence is common in other malignancies as well. According to Shen et al., in primary cutaneous melanoma the mean disease-free interval after surgery was 182 months [14] whereas Briele et al., report seven patients in whom local or regional recurrence occured 11 to 23 years after first treatment of melanoma [15]. Another neoplasm after a treatment of which long-term follow-up is essential is medulloblastoma as recurrences after the Collins' risk period (i.e. age of a patient plus 9 months) have been noticed [16, 17]. The average follow-up in case of rectal cancer surgical treatment is 2 years whereas research shows that local recurrence can become evident even after 5.8 years and systemic recurrence after 7.9 years [18]. Continued long-term follow-up in patients treated for above mentioned malignancies proves beneficial [15, 17, 19].

Conclusion

Every patient treated due to a malignant or borderline hemangiopericytoma should be under long-term oncological follow-up as the risk of recurrence and distant metastases even after many years is very high.

Acknowledgements

The written consent was obtained from the patient for publication of this case report.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://​creativecommons.​org/​licenses/​by/​2.​0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Competing interests

The authors declare that they have no competing interests.

Authors' contributions

MS conceived the idea for the study, participated in its design and coordination, analyzed the data, wrote the first draft of the manuscript.
IP conducted the literature review, was involved in data collection, analyzed the data, helped to draft the manuscript.
ZW participated in the study design and coordination, helped to draft the manuscript.
All authors read and approved the final version of the manuscript.
Anhänge

Authors’ original submitted files for images

Literatur
1.
Zurück zum Zitat Enzinger FM, Smith BH: Hemangiopericytoma. An analysis of 106 cases. Hum Pathol. 1976, 7: 61-82. 10.1016/S0046-8177(76)80006-8.CrossRefPubMed Enzinger FM, Smith BH: Hemangiopericytoma. An analysis of 106 cases. Hum Pathol. 1976, 7: 61-82. 10.1016/S0046-8177(76)80006-8.CrossRefPubMed
2.
Zurück zum Zitat Smith RT, Small WC, Mansour K: Case report: hemangiopericytoma of the oesophagus. Br J Radiol. 1995, 68: 1031-1033.CrossRefPubMed Smith RT, Small WC, Mansour K: Case report: hemangiopericytoma of the oesophagus. Br J Radiol. 1995, 68: 1031-1033.CrossRefPubMed
3.
Zurück zum Zitat Goldman S, Davidson A, Neal J: Retroperitoneal and pelvic hemangiopericytomas: clinical, radiologic, and pathologic correlation. Radiology. 1988, 168: 13-17.CrossRefPubMed Goldman S, Davidson A, Neal J: Retroperitoneal and pelvic hemangiopericytomas: clinical, radiologic, and pathologic correlation. Radiology. 1988, 168: 13-17.CrossRefPubMed
4.
Zurück zum Zitat Stout AP: Tumors featuring pericytes. Glomus tumor and hemangiopericytoma. Lab Invest. 1956, 5: 217-223.PubMed Stout AP: Tumors featuring pericytes. Glomus tumor and hemangiopericytoma. Lab Invest. 1956, 5: 217-223.PubMed
5.
Zurück zum Zitat Craven JP, Quigley TM, Bolen JW, Raker EJ: Current management and clinical outcome of hemangiopericytomas. Am J Surg. 1992, 163: 490-493. 10.1016/0002-9610(92)90394-7.CrossRefPubMed Craven JP, Quigley TM, Bolen JW, Raker EJ: Current management and clinical outcome of hemangiopericytomas. Am J Surg. 1992, 163: 490-493. 10.1016/0002-9610(92)90394-7.CrossRefPubMed
6.
Zurück zum Zitat McMaster MJ, Soule EH, Ivins JC: Hemangiopericytoma. A clinicopathologic study and long-term follow up of 60 patients. Cancer. 1975, 36: 2232-2244.CrossRefPubMed McMaster MJ, Soule EH, Ivins JC: Hemangiopericytoma. A clinicopathologic study and long-term follow up of 60 patients. Cancer. 1975, 36: 2232-2244.CrossRefPubMed
7.
Zurück zum Zitat Panda A, Dayal Y, Singhal V, Pattnaik NK: Hemangiopericytoma. Br J Opht. 1984, 68: 124-127.CrossRef Panda A, Dayal Y, Singhal V, Pattnaik NK: Hemangiopericytoma. Br J Opht. 1984, 68: 124-127.CrossRef
8.
Zurück zum Zitat Sabini P, Josephson GD, Yung RT, Dolitsky JN: Hemangiopericytoma presenting as a congenital midline nasal mass. Arch Otolaryngol Head Neck Surg. 1998, 124: 202-204.CrossRefPubMed Sabini P, Josephson GD, Yung RT, Dolitsky JN: Hemangiopericytoma presenting as a congenital midline nasal mass. Arch Otolaryngol Head Neck Surg. 1998, 124: 202-204.CrossRefPubMed
9.
Zurück zum Zitat Binder SC, Wolfe HJ, Deterling RA: Intraabdomnal hemangiopericytoma: report of four cases and review of the literature. Arch Surg. 1973, 107: 536-543.CrossRefPubMed Binder SC, Wolfe HJ, Deterling RA: Intraabdomnal hemangiopericytoma: report of four cases and review of the literature. Arch Surg. 1973, 107: 536-543.CrossRefPubMed
10.
Zurück zum Zitat Felix EL, Wood DK, Das Gupta TK: Tumors of the retroperitoneum. Current problems in cancer. Edited by: Hickey RC, Clark RL, Benfield JR, Hurter R, Moertel CC, Shingleton W. 1981, Chicago: Year Book Medical, 1-47. 10.1016/S0147-0272(81)80011-6. Felix EL, Wood DK, Das Gupta TK: Tumors of the retroperitoneum. Current problems in cancer. Edited by: Hickey RC, Clark RL, Benfield JR, Hurter R, Moertel CC, Shingleton W. 1981, Chicago: Year Book Medical, 1-47. 10.1016/S0147-0272(81)80011-6.
11.
Zurück zum Zitat Pandey M, Ahmed MI, Abraham EK, Sebastian P: Recurrent Hemangiopericytoma metastasizing to pleura: A case report. Indian J Surg. 2002, 64: 183-185. Pandey M, Ahmed MI, Abraham EK, Sebastian P: Recurrent Hemangiopericytoma metastasizing to pleura: A case report. Indian J Surg. 2002, 64: 183-185.
12.
Zurück zum Zitat Dempke W, Firusian N: Unusual course of hemangiopericytoma. Med Klin (Munich). 1998, 93: 726-728.CrossRef Dempke W, Firusian N: Unusual course of hemangiopericytoma. Med Klin (Munich). 1998, 93: 726-728.CrossRef
13.
Zurück zum Zitat Pandey M, Kothari KC, Patel DD: Hemangiopericytoma. Current status, diagnosis and management. Eur J Surg Oncol. 1997, 23: 282-285. 10.1016/S0748-7983(97)90534-5.CrossRefPubMed Pandey M, Kothari KC, Patel DD: Hemangiopericytoma. Current status, diagnosis and management. Eur J Surg Oncol. 1997, 23: 282-285. 10.1016/S0748-7983(97)90534-5.CrossRefPubMed
14.
Zurück zum Zitat Shen P, Guenther JM, Wanek LA, Morton DL: Can elective lymph node dissection decrease the frequency and mortality rate of late melanoma recurrences?. Ann Surg Oncol. 2000, 7: 114-119. 10.1007/s10434-000-0114-x.CrossRefPubMed Shen P, Guenther JM, Wanek LA, Morton DL: Can elective lymph node dissection decrease the frequency and mortality rate of late melanoma recurrences?. Ann Surg Oncol. 2000, 7: 114-119. 10.1007/s10434-000-0114-x.CrossRefPubMed
15.
Zurück zum Zitat Briele HA, Beattie CW, Ronan SG, Chaudhuri PK, Das Gupta TK: Late recurrence of cutaneous melanoma. Arch Surg. 1983, 118: 800-803.CrossRefPubMed Briele HA, Beattie CW, Ronan SG, Chaudhuri PK, Das Gupta TK: Late recurrence of cutaneous melanoma. Arch Surg. 1983, 118: 800-803.CrossRefPubMed
16.
Zurück zum Zitat King GA, Sagerman RH: Late recurrence in medulloblastoma. Am J Roentgenol Radium Ther Nucl Med. 1975, 123: 7-12.CrossRefPubMed King GA, Sagerman RH: Late recurrence in medulloblastoma. Am J Roentgenol Radium Ther Nucl Med. 1975, 123: 7-12.CrossRefPubMed
17.
Zurück zum Zitat Nishio S, Morioka T, Takeshita I, Fukui M: Medulloblastoma: Survival and late recurrence after the Collins' risk period. Neurosurg Rev. 1997, 20: 245-249. 10.1007/BF01105895.CrossRefPubMed Nishio S, Morioka T, Takeshita I, Fukui M: Medulloblastoma: Survival and late recurrence after the Collins' risk period. Neurosurg Rev. 1997, 20: 245-249. 10.1007/BF01105895.CrossRefPubMed
18.
Zurück zum Zitat Moore E, Heald RJ, Cecil TD, Sharpe GD, Sexton R, Moran BJ: Almost all five year disease free survivors are cured following rectal cancer surgery, but longer term follow-up detects some late local and systemic recurrences. Colorectal Dis. 2005, 7: 403-5. 10.1111/j.1463-1318.2005.00791.x.CrossRefPubMed Moore E, Heald RJ, Cecil TD, Sharpe GD, Sexton R, Moran BJ: Almost all five year disease free survivors are cured following rectal cancer surgery, but longer term follow-up detects some late local and systemic recurrences. Colorectal Dis. 2005, 7: 403-5. 10.1111/j.1463-1318.2005.00791.x.CrossRefPubMed
19.
Zurück zum Zitat Koh HK, Sober AJ, Fitzpatrick TB: Late recurrence (beyond ten years) of cutaneous malignant melanoma. Report of two cases and a review of the literature. JAMA. 1984, 251: 1859-1862. 10.1001/jama.251.14.1859.CrossRefPubMed Koh HK, Sober AJ, Fitzpatrick TB: Late recurrence (beyond ten years) of cutaneous malignant melanoma. Report of two cases and a review of the literature. JAMA. 1984, 251: 1859-1862. 10.1001/jama.251.14.1859.CrossRefPubMed
Metadaten
Titel
Local recurrence and distant metastases 18 years after resection of the greater omentum hemangiopericytoma
verfasst von
Maciej Slupski
Ilona Piotrowiak
Zbigniew Wlodarczyk
Publikationsdatum
01.12.2007
Verlag
BioMed Central
Erschienen in
World Journal of Surgical Oncology / Ausgabe 1/2007
Elektronische ISSN: 1477-7819
DOI
https://doi.org/10.1186/1477-7819-5-63

Weitere Artikel der Ausgabe 1/2007

World Journal of Surgical Oncology 1/2007 Zur Ausgabe

Chirurginnen nehmen sich Zwischenfälle im OP besonders zu Herzen

05.06.2024 Allgemeine Chirurgie Nachrichten

Selbstverschuldete Fehler oder unerwartete Komplikationen machen jungen Chirurginnen und Operateuren mit Migrationshintergrund offenbar besonders zu schaffen. Benötigt werden routinemäßige Programme zum Umgang mit Zwischenfällen im OP.

Schützt auch die medikamentöse Gewichtsreduktion vor Krebs?

03.06.2024 ASCO 2024 Kongressbericht

Offenbar muss es nicht immer die bariatrische Chirurgie sein, wenn es darum geht, durch deutlichen Gewichtsverlust auch das Krebsrisiko günstig zu beeinflussen. Eine große Kohortenanalyse zur Behandlung mit GLP-1-Agonisten wurde dazu auf der ASCO-Tagung vorgestellt.

Häusliche Gewalt in der orthopädischen Notaufnahme oft nicht erkannt

28.05.2024 Häusliche Gewalt Nachrichten

In der Notaufnahme wird die Chance, Opfer von häuslicher Gewalt zu identifizieren, von Orthopäden und Orthopädinnen offenbar zu wenig genutzt. Darauf deuten die Ergebnisse einer Fragebogenstudie an der Sahlgrenska-Universität in Schweden hin.

Fehlerkultur in der Medizin – Offenheit zählt!

28.05.2024 Fehlerkultur Podcast

Darüber reden und aus Fehlern lernen, sollte das Motto in der Medizin lauten. Und zwar nicht nur im Sinne der Patientensicherheit. Eine negative Fehlerkultur kann auch die Behandelnden ernsthaft krank machen, warnt Prof. Dr. Reinhard Strametz. Ein Plädoyer und ein Leitfaden für den offenen Umgang mit kritischen Ereignissen in Medizin und Pflege.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.